NPCE
Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Earlier roles on record: CFO at NeuroPace Inc (NPCE) until June 20, 2025. NeuroPace Inc reported in an 8-K filed June 24, 2025 that Rebecca Kuhn resigned as Chief Financial Officer and Vice President, Finance and Administration, effective June 20, 2025. The proxy statement of NeuroPace Inc reports total compensation of $846,308 for Rebecca Kuhn in fiscal 2025, including a base salary of $268,166. Disclosed compensation is on record for 3 fiscal years. Rebecca Kuhn has spoken on 17 earnings calls across 1 company, most recently for NeuroPace Inc on May 13, 2025. The companies whose calls Rebecca Kuhn spoke on are classified in the Healthcare sector.
“On June 20, 2025, Rebecca Kuhn departed from her position as Chief Financial Officer and Vice President, Finance and Administration of NeuroPace, Inc. (the "Company") and will transition to the role of Senior Strategic Advisor—Finance, effective as of June 20, 2025 (the "Transition Date").”
“Our revenue was $22.5 million for the first quarter of 2025, representing growth of 24% compared to $18.1 million for the first quarter of 2024. Revenue growth was primarily driven by increased sales of the RNS System, which grew 26% compared to the prior year.”
“Our team has been hard at work and it is great to see these efforts reflected in our financial results in the fourth quarter as well as the building of momentum that will help drive our projected growth in the future.”
“Our team has continued to make tremendous progress in executing against our strategy.”
“NeuroPace's revenue for the second quarter of 2024 was $19.3 million, representing growth of 17% compared to $16.5 million for the second quarter of 2023. This growth was primarily driven by increased sales of our RNS system.”
“NeuroPace revenue for the first quarter of 2024 was $18.1 million, representing growth of 25% compared to $14.5 million for the first quarter of 2023. This growth was primarily driven by increased sales of our RNS System.”
Start not stated–2025-06-20
NPCE
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | NeuroPace Inc (NPCE) | Former Chief Financial Officer, Vice President, Finance and Administration | $268,166 | $846,308 |
| 2024 | NeuroPace Inc (NPCE) | Chief Financial Officer, Vice President, Finance and Administration | $416,205 | $1,093,306 |
| 2023 | NeuroPace Inc (NPCE) | Chief Financial Officer, Vice President, Finance and Administration | $403,545 | $994,911 |